Peter R. Breggin, M.D. began in the full time private practice of psychiatry in 1968.  Dr. Breggin has been informing the professions, media and the public about the potential dangers of drugs, electroshock, psychosurgery, involuntary treatment, and the biological theories of psychiatry for over three decades.  He is the author of dozens of scientific articles and nineteen professional books, many dealing with psychiatric medication, the FDA and drug approval process, the evaluation of clinical trials, and standards of care in psychiatry and related fields. 
      In 1972 he founded The International Center for the Study of Psychiatry and Psychology (ICSPP) as a nonprofit research and educational network.  The Center is concerned with the impact of mental health theory and practices upon individual well-being, personal freedom, and family and community values.  He also founded the peer-review journal, Ethical Human Sciences and Services.  In 2002, Dr. Breggin and his wife Ginger selected new and younger professionals to take over leadership of the journal and ICSPP (see ICSPP.org).
      For thirty years Dr. Breggin has served as a medical expert in many civil and criminal suits including individual malpractice cases andproduct liability suits against the manufacturers of psychiatric drugs.  His work provided the scientific basis for the original combined Prozac suits, for the more recent Ritalin class action suits, and for label changes in many psychiatric drugs. 
      Dr. Breggin's background includes Harvard College, Case Western Reserve Medical School, a teaching fellowship at Harvard Medical School, a two-year staff appointment to the National Institute of Mental Health (NIMH), and a faculty appointment to the Johns Hopkins University Department of Counseling.